Active Ingredient(s): Ponatinib
FDA Approved: * December 14, 2012
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Iclusig Overview

Ponatinib (trade name Iclusig /aklus/ eye-KLOO-sig, previously AP24534) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor.[2] Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these...

Read more Iclusig Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ponatinib

Recent Iclusig Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 10mg, 15mg, 30mg, 45mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Iclusig: (7 results)

Sorted by National Drug Code
  • 63020-533 Iclusig 30 mg Oral Tablet, Film Coated by Millenium Pharmaceuticals Inc.
  • 63020-534 Iclusig 45 mg Oral Tablet, Film Coated by Millenium Pharmaceuticals Inc.
  • 63020-535 Iclusig 15 mg Oral Tablet, Film Coated by Millenium Pharmaceuticals Inc.
  • 63020-536 Iclusig 10 mg Oral Tablet, Film Coated by Millennium Pharmaceuticals, Inc.
  • 76189-533 Iclusig 30 mg Oral Tablet, Film Coated by Ariad Pharmaceuticals, Inc.
  • 76189-534 Iclusig (As Ponatinib Hydrochloride) 45 mg Oral Tablet by Ariad Pharmaceuticals, Inc.
  • 76189-535 Iclusig (As Ponatinib Hydrochloride) 15 mg Oral Tablet by Ariad Pharmaceuticals, Inc.

Other drugs which contain Ponatinib or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA